Revagenix

Revagenix is a biopharmaceutical company focused on discovering and developing novel antibiotics to combat multidrug-resistant organisms. They are advancing a pipeline of antibiotic programs designed to treat infections caused by these organisms, addressing a critical unmet medical need. The company leverages a team of seasoned experts and strategic collaborations to develop next-generation antibiotic treatments.


Buy Funded Startups lists

Funding Round: Series B

Funding Amount:

Date: 05-Jan-2024

Investors: Tenmile, Novo Holdings

Markets: Biopharmaceutical, Antibiotics, Biotechnology, Pharmaceutical, Service Industry

HQ: San Mateo, California, United States

Founded: 2019

Website: https://www.revagenix.com/

LinkedIn: https://www.linkedin.com/company/revagenix-inc

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/revagenix

Pitchbook: https://pitchbook.com/profiles/company/464154-22


Leave a Comment